TITLE:
Bupropion for the Treatment of Methamphetamine Dependence - 1

CONDITION:
Amphetamine-Related Disorders

INTERVENTION:
Bupropion

SUMMARY:

      The purpose of this study is to assess the efficacy and safety of bupropion in reducing
      methamphetamine use in subjects with methamphetamine dependence
    

DETAILED DESCRIPTION:

      A double-blind, placebo-controlled, parallel-group design study in which 100 subjects will
      be randomly assigned to placebo or bupropion for 12 weeks with follow-up assessments 4 weeks
      following treatment. Adaptive randomization will be used to balance treatment groups based
      on gender.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Subject must have methamphetamine dependence as determined by the DSM-IV diagnosis

          -  Subject must be willing to comply with study procedures.

          -  Ability to verbalize understanding of consent form, provide written consent, and
             verbalize willingness to complete study procedures

          -  Be able to comply with protocol requirements

        Exclusion Criteria:

          -  Please contact site for more information.
      
